Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis

Authors: Florence Oberkampf, Maya Gutierrez, Olfa Trabelsi Grati, Émilie Le Rhun, Olivier Trédan, Isabelle Turbiez, Amir Kadi, Coraline Dubot, Sophie Taillibert, Sophie Vacher, Claire Bonneau

Published: 2022-07-22

DOI: 10.1093/neuonc/noac180

Source: Full article

Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis

Abstract